A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The objective of the randomized controlled study is to compare combination of sublingual
misoprostol and routine uterotonics versus routine uterotonics alone on PPH in low risk women
after vaginal delivery. The hypothesis is that combination of sublingual misoprostol and
routine uterotonics is more effective than routine uterotonics alone in reduction of PPH in
low risk women after vaginal delivery.